Cancers | M6A-modified lncRNAs | Expression level | Functions | References |
---|---|---|---|---|
Colorectal cancer | XIST | Upregulated | Promote cell proliferation and metastasis | [107] |
GAS5 | Downregulated | Inhibit cancer progression | [108] | |
RP11 | Upregulated | Promote metastasis | [110] | |
Gastric cancer | LINC01320 | Upregulated | Promote cell proliferation | [92] |
THAP7-AS1 | Upregulated | Promote metastasis and cell proliferation | [113] | |
Esophageal squamous cell carcinoma | LINC00022 | Upregulated | Promote cell proliferation | [116] |
MALAT1 | / | Promote metastasis | [90] | |
Hepatocellular carcinoma | lnc-CTHCC | Upregulated | Promote angiogenesis | [96] |
LNCAROD | Upregulated | Promote glycolysis | [98] | |
LINC00958 | Upregulated | Facilitate lipogenesis | [118] | |
Pancreatic cancer | DICER1-AS1 | Downregulated | Inhibit glycolysis | [99] |
WTAPP1 | Upregulated | Promote cell proliferation | [122] | |
KCNK15-AS1 | Downregulated | Inhibit cell proliferation | [123] | |
Nasopharyngeal carcinoma | ZFAS1 | Upregulated | Regulate autophagy level | [127] |
FAM225A | Upregulated | Promote cell proliferation | [128] | |
Lung cancer | MALAT1 | Upregulated | Promote drug resistance and metastasis | [135] |
ABHD11-AS1 | Upregulated | Promote glycolysis | [136] | |
AC138035.1 et al. | / | / | [138] | |
SVIL-AS1 | Downregulated | Inhibit cell proliferation | [142] | |
Prostate cancer | NEAT1-1 | Upregulated | Promote metastasis | [88] |
PCAT6 | Upregulated | Promote metastasis | [89] | |
Cervical cancer | KCNMB2-AS1 | Upregulated | Facilitate cancer progression | [144] |
FOXD2-AS1 | Upregulated | Facilitate cancer progression | [145] | |
Endometrial carcinoma | FENDDR | Downregulated | Inhibit cell proliferation | [93] |
AL645568.1 et al. | / | / | [148] | |
Ovarian cancer | AC010894.3 et al. | / | / | [150] |
AC008669.1 et al. | / | / | [151] | |
RHPN1-AS1 | Upregulated | Promote cell proliferation and metastasis | [152] | |
Bladder cancer | AC020911.1 et al. | / | / | [155] |
ZNRD1-AS1 et al. | / | / | [156] | |
Renal cell carcinoma | NEAT1 | Downregulated | Inhibit cell proliferation | [158] |
Lnc-LSG1 | Downregulated | Inhibit metastasis | [159] | |
Thyroid cancer | HAGLR | Upregulated | Promote cell proliferation | [162] |
MALAT1 | Upregulated | Promote cell proliferation | ||
PSMG3-AS1 et al. | / | / | [167] | |
AC139795.2 et al. | / | / | [168] | |
Breast cancer | MIR210HG | Upregulated | Promote cell proliferation | [172] |
LINC00958 | Upregulated | Promote cell proliferation | [173] | |
Multiple myeloma | LOC606724 | Upregulated | Promote drug resistance | [101] |
SNHG1 | Upregulated | Promote drug resistance | [101] | |
Lymphoma | TRERNA1 | Upregulated | Promote cell proliferation | [177] |
Leukemia | NEAT1 | Downregulated | Promote apoptosis | [180] |
AC025430.1 et al. | / | / | [182] | |
Osteosarcoma | ZBTB32 et al. | / | / | [186] |
AP003119.2 et al. | / | / | [187] | |
FOXD2-AS1 | Upregulated | Promote cell proliferation and metastasis | ||
PVT1 | Upregulated | Promote cell proliferation | ||
Skin cutaneous melanoma | RP11-775D22.3 et al. | / | / | [195] |
Glioma | C6orf3 et al. | / | / | [198] |
Glioblastoma | CASC9 | Upregulated | Promote glycolysis | [200] |
Head and neck squamous cell carcinoma | GRHL3-AS1 et al. | / | / | [203] |
LNCAROD | Upregulated | Promote cell proliferation | [204] | |
Oral squamous cell carcinoma | AC079684.2 et al. | / | / | [206] |
MALAT1 | Upregulated | Promote cell proliferation | [207] | |
Laryngeal squamous cell carcinoma | KCNQ1OT1 | Upregulated | Promote cell proliferation | [209] |